0001104659-21-100287.txt : 20210804 0001104659-21-100287.hdr.sgml : 20210804 20210804210433 ACCESSION NUMBER: 0001104659-21-100287 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bourdow Carrie L. CENTRAL INDEX KEY: 0001638989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 211145912 MAIL ADDRESS: STREET 1: C/O TREVENA, INC. STREET 2: 1018 WEST 8TH AVENUE, SUITE A CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2123911-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-08-02 0 0001641640 Nabriva Therapeutics plc NBRV 0001638989 Bourdow Carrie L. 414 COMMERCE DRIVE SUITE 120 FORT WASHINGTON PA 19034 1 0 0 0 Ordinary Shares 2021-08-02 4 S 0 777 1.20 D 18473 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.205, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Robert Crotty, by power of attorney 2021-08-04